Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Kao

Concepts (373)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
35
2026
2326
4.930
Why?
Machine Learning
8
2025
587
2.230
Why?
Stroke Volume
17
2025
655
1.870
Why?
Adrenergic beta-Antagonists
10
2025
252
1.520
Why?
Methadone
5
2023
123
1.410
Why?
Pregnancy Complications, Cardiovascular
5
2022
85
1.400
Why?
Buprenorphine
3
2023
192
1.300
Why?
Cardiomyopathies
5
2022
335
1.300
Why?
United States Food and Drug Administration
5
2024
208
1.190
Why?
Decision Support Systems, Clinical
6
2024
273
1.140
Why?
Cardiomyopathy, Dilated
9
2025
356
1.110
Why?
Pharmacogenetics
5
2024
175
1.110
Why?
Adverse Drug Reaction Reporting Systems
4
2024
81
1.070
Why?
Arrhythmias, Cardiac
6
2023
356
1.040
Why?
Cytochrome P-450 CYP2C19
4
2024
27
0.960
Why?
Electronic Health Records
7
2024
1202
0.940
Why?
Propanolamines
3
2019
40
0.890
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
444
0.850
Why?
Hospitalization
10
2024
2460
0.830
Why?
Workflow
2
2026
183
0.820
Why?
Telemedicine
4
2024
966
0.740
Why?
Atrial Fibrillation
5
2026
558
0.730
Why?
Torsades de Pointes
4
2016
23
0.710
Why?
Seasons
1
2024
538
0.710
Why?
Pulmonary Edema
1
2021
105
0.680
Why?
Humans
88
2026
145763
0.680
Why?
Coffee
1
2021
15
0.670
Why?
Pharmacogenomic Testing
4
2022
63
0.640
Why?
Stroke
2
2021
1271
0.630
Why?
Platelet Aggregation Inhibitors
1
2024
499
0.620
Why?
Aged
33
2026
26215
0.600
Why?
Defibrillators, Implantable
2
2021
387
0.600
Why?
Artificial Intelligence
2
2026
381
0.590
Why?
Prosthesis Failure
1
2020
125
0.580
Why?
Prosthesis-Related Infections
1
2020
98
0.580
Why?
Long QT Syndrome
3
2016
68
0.570
Why?
Mobile Applications
1
2021
199
0.570
Why?
Spironolactone
1
2019
40
0.560
Why?
Device Removal
1
2020
142
0.560
Why?
United States
22
2025
16123
0.560
Why?
Pacemaker, Artificial
1
2020
128
0.560
Why?
Risk Assessment
10
2026
3752
0.560
Why?
Medical Records
2
2019
192
0.550
Why?
Coronary Disease
1
2021
382
0.550
Why?
Mineralocorticoid Receptor Antagonists
1
2019
69
0.540
Why?
Diabetes Mellitus
2
2024
1101
0.540
Why?
Biomedical Research
2
2024
719
0.530
Why?
Periodicals as Topic
1
2020
209
0.530
Why?
Mortality
3
2019
380
0.520
Why?
Retrospective Studies
22
2026
17325
0.510
Why?
Hypertension, Pregnancy-Induced
1
2018
69
0.500
Why?
Receptors, Transforming Growth Factor beta
1
2017
55
0.490
Why?
Female
50
2026
79035
0.490
Why?
Hospital Records
1
2016
10
0.490
Why?
Proteoglycans
1
2017
112
0.480
Why?
Ventricular Function, Left
5
2025
544
0.480
Why?
Analgesics, Opioid
2
2023
1154
0.470
Why?
Hospital Mortality
6
2024
1038
0.470
Why?
Disease Management
1
2020
653
0.450
Why?
Survival
1
2015
38
0.450
Why?
Tetrazoles
1
2015
50
0.440
Why?
Male
42
2026
73003
0.440
Why?
Electrocardiography
5
2026
668
0.440
Why?
Middle Aged
30
2025
36302
0.440
Why?
Biphenyl Compounds
1
2015
67
0.440
Why?
Muscle Proteins
2
2025
243
0.430
Why?
Myocardial Infarction
3
2018
1211
0.420
Why?
Research Design
1
2020
1139
0.410
Why?
Ventricular Remodeling
3
2025
278
0.400
Why?
Loperamide
2
2023
12
0.400
Why?
Myocardium
3
2017
935
0.390
Why?
Tachycardia, Ventricular
1
2015
180
0.380
Why?
Polymorphism, Single Nucleotide
4
2017
2181
0.380
Why?
Diet
1
2021
1278
0.380
Why?
Registries
2
2020
2410
0.380
Why?
Precision Medicine
6
2024
461
0.370
Why?
Legislation, Medical
1
2012
11
0.370
Why?
Adult
28
2024
40872
0.370
Why?
Amiodarone
1
2012
31
0.360
Why?
Peripartum Period
4
2022
19
0.360
Why?
Phenotype
5
2025
3170
0.360
Why?
Patient Readmission
1
2018
772
0.350
Why?
Quality Improvement
2
2020
1296
0.350
Why?
Anti-Arrhythmia Agents
1
2012
144
0.340
Why?
Sex Factors
4
2024
2110
0.330
Why?
Pyrazines
2
2008
94
0.330
Why?
Heart Arrest
4
2019
411
0.330
Why?
Catheter Ablation
1
2015
355
0.330
Why?
Cardiovascular Diseases
5
2024
2191
0.320
Why?
Transfusion Reaction
1
2011
61
0.320
Why?
Treatment Outcome
10
2025
11793
0.320
Why?
Forecasting
2
2024
390
0.320
Why?
Heart-Assist Devices
1
2016
568
0.310
Why?
Triazoles
2
2008
191
0.310
Why?
Echocardiography
3
2024
648
0.310
Why?
Risk Factors
10
2025
10917
0.310
Why?
Postoperative Complications
2
2020
2977
0.300
Why?
Insurance, Health
1
2012
311
0.300
Why?
Patient Discharge
2
2021
995
0.290
Why?
Patient Transfer
1
2012
211
0.290
Why?
Databases, Factual
5
2020
1491
0.290
Why?
Anemia
1
2011
191
0.290
Why?
Thiazolidinediones
1
2010
143
0.290
Why?
Genotype
3
2024
1857
0.290
Why?
Marketing
1
2008
23
0.280
Why?
Renal Insufficiency
1
2011
172
0.280
Why?
Rhabdomyolysis
1
2008
24
0.280
Why?
Drug Industry
1
2008
49
0.280
Why?
Aged, 80 and over
7
2024
8346
0.280
Why?
Simvastatin
1
2008
59
0.280
Why?
Heart Ventricles
4
2017
756
0.270
Why?
Receptors, Adrenergic, beta-1
4
2019
24
0.270
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2008
46
0.270
Why?
Incidence
6
2025
2933
0.270
Why?
Heart Rate
3
2025
856
0.270
Why?
Follow-Up Studies
7
2025
5428
0.260
Why?
Length of Stay
4
2024
1350
0.260
Why?
Cytochrome P-450 CYP2D6
3
2022
32
0.260
Why?
Kaplan-Meier Estimate
3
2016
971
0.260
Why?
Proportional Hazards Models
4
2021
1330
0.250
Why?
Pharmacovigilance
2
2024
24
0.250
Why?
Practice Patterns, Physicians'
3
2020
1372
0.240
Why?
Elective Surgical Procedures
2
2020
203
0.240
Why?
Biological Specimen Banks
3
2024
118
0.230
Why?
Atrial Flutter
1
2026
47
0.230
Why?
Gene Expression Regulation
1
2015
2601
0.230
Why?
Emergency Service, Hospital
2
2020
2383
0.220
Why?
Patient Reported Outcome Measures
2
2020
498
0.220
Why?
Cause of Death
2
2019
471
0.220
Why?
Glucose
1
2010
1048
0.210
Why?
New York
1
2024
128
0.210
Why?
Diabetic Cardiomyopathies
1
2024
34
0.210
Why?
Pandemics
3
2022
1711
0.210
Why?
Young Adult
9
2022
14251
0.200
Why?
Pregnancy
6
2022
7215
0.200
Why?
Diphenoxylate
1
2023
5
0.200
Why?
Acute Kidney Injury
2
2008
874
0.200
Why?
Adolescent
10
2020
22573
0.190
Why?
Randomized Controlled Trials as Topic
3
2021
1751
0.190
Why?
Monitoring, Physiologic
1
2024
289
0.190
Why?
Nonprescription Drugs
1
2023
69
0.190
Why?
Heart Defects, Congenital
2
2020
910
0.180
Why?
Prognosis
5
2020
4329
0.180
Why?
Naltrexone
1
2023
115
0.180
Why?
Algorithms
4
2025
1850
0.180
Why?
Medicare
2
2020
904
0.180
Why?
Insulin Resistance
1
2010
1244
0.170
Why?
Red Meat
1
2021
7
0.170
Why?
Speech
1
2021
76
0.170
Why?
Hypertension
2
2020
1276
0.170
Why?
Time Factors
3
2020
7133
0.160
Why?
Data Interpretation, Statistical
2
2020
368
0.160
Why?
Losartan
1
2020
13
0.160
Why?
Lisinopril
1
2020
15
0.160
Why?
Drug Dosage Calculations
1
2020
27
0.160
Why?
Protective Factors
1
2021
99
0.160
Why?
Angioedema
1
2020
16
0.160
Why?
Smartphone
1
2021
107
0.160
Why?
Actigraphy
1
2021
148
0.160
Why?
Cardiac Resynchronization Therapy
1
2021
63
0.160
Why?
Wearable Electronic Devices
1
2021
69
0.160
Why?
American Heart Association
2
2019
358
0.160
Why?
Milk
1
2021
119
0.160
Why?
Hypoglycemic Agents
1
2010
1399
0.160
Why?
Data Accuracy
1
2020
65
0.160
Why?
Turner Syndrome
1
2021
65
0.160
Why?
Indans
1
2020
13
0.150
Why?
Editorial Policies
1
2020
45
0.150
Why?
Oxadiazoles
1
2020
37
0.150
Why?
Bionics
1
2019
14
0.150
Why?
Biological Products
1
2023
257
0.150
Why?
California
2
2012
473
0.150
Why?
Medical Informatics
1
2020
100
0.150
Why?
Fingolimod Hydrochloride
1
2020
40
0.150
Why?
Medical Futility
1
2019
32
0.150
Why?
Referral and Consultation
2
2017
868
0.150
Why?
Software
2
2015
680
0.150
Why?
Medical Record Linkage
1
2020
69
0.150
Why?
Prescription Drugs
1
2020
111
0.150
Why?
Information Storage and Retrieval
1
2020
123
0.140
Why?
Drug Overdose
1
2023
375
0.140
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2020
83
0.140
Why?
Sitagliptin Phosphate
2
2008
31
0.140
Why?
Medical Order Entry Systems
1
2019
40
0.140
Why?
Drug Prescriptions
1
2021
288
0.140
Why?
Dose-Response Relationship, Drug
4
2020
2028
0.140
Why?
Child Health Services
1
2020
186
0.140
Why?
Tobacco Use
1
2019
62
0.140
Why?
Cluster Analysis
1
2019
501
0.140
Why?
Computer Graphics
2
2015
41
0.140
Why?
Cohort Studies
3
2021
6032
0.140
Why?
Social Determinants of Health
1
2022
309
0.130
Why?
Receptors, Histamine H2
1
2017
6
0.130
Why?
Gene Regulatory Networks
2
2023
318
0.130
Why?
Florida
1
2018
117
0.130
Why?
Advisory Committees
1
2019
229
0.130
Why?
Neisseria gonorrhoeae
1
1997
29
0.130
Why?
Porins
1
1997
18
0.130
Why?
Consensus
1
2019
479
0.130
Why?
Dyslipidemias
1
2019
184
0.130
Why?
Nursing Assessment
1
2017
54
0.120
Why?
Prospective Studies
4
2021
8075
0.120
Why?
Pressure Ulcer
1
2017
40
0.120
Why?
Academic Medical Centers
1
2020
554
0.120
Why?
Heart Diseases
1
2020
341
0.120
Why?
Population Surveillance
1
2020
484
0.120
Why?
Patient Participation
1
2020
446
0.120
Why?
Antihypertensive Agents
1
2020
521
0.120
Why?
Hospitals, Teaching
1
2017
121
0.120
Why?
Tilidine
1
2016
2
0.120
Why?
Cardiology
1
2019
362
0.120
Why?
Genetic Markers
1
2017
338
0.120
Why?
Double-Blind Method
3
2025
2064
0.110
Why?
Oxycodone
1
2016
52
0.110
Why?
Databases, Genetic
1
2017
238
0.110
Why?
Rheumatic Fever
1
2015
6
0.110
Why?
Rheumatic Heart Disease
1
2015
5
0.110
Why?
Sex Distribution
1
2016
388
0.110
Why?
Angiotensin II Type 1 Receptor Blockers
1
2015
38
0.110
Why?
Cholesterol Ester Transfer Proteins
1
2015
22
0.110
Why?
Hospitals, Low-Volume
1
2015
26
0.110
Why?
Gene Expression Profiling
3
2017
1777
0.110
Why?
Immunosuppressive Agents
1
2020
838
0.110
Why?
Angiotensin II
1
2015
102
0.110
Why?
Oligonucleotide Array Sequence Analysis
1
2017
751
0.110
Why?
Computational Biology
2
2017
669
0.110
Why?
Naloxone
1
2016
132
0.110
Why?
Hospitals, High-Volume
1
2015
50
0.110
Why?
Mothers
1
2020
765
0.100
Why?
Marijuana Use
1
2018
222
0.100
Why?
United Kingdom
1
2015
358
0.100
Why?
Percutaneous Coronary Intervention
1
2020
549
0.100
Why?
Biomarkers
2
2024
4302
0.100
Why?
Age Factors
2
2019
3346
0.100
Why?
International Classification of Diseases
1
2015
150
0.100
Why?
Comorbidity
1
2019
1662
0.100
Why?
Chronic Disease
2
2020
1812
0.100
Why?
Gene Expression
2
2017
1478
0.100
Why?
MicroRNAs
2
2017
686
0.100
Why?
Down-Regulation
1
2015
618
0.100
Why?
Narcotic Antagonists
1
2015
203
0.100
Why?
Cholesterol
1
2015
408
0.100
Why?
Ventricular Dysfunction, Left
2
2020
394
0.090
Why?
Federal Government
1
2012
23
0.090
Why?
Coronary Artery Disease
1
2019
750
0.090
Why?
RNA, Messenger
2
2017
2805
0.090
Why?
Drug Resistance
1
2012
145
0.090
Why?
Myocytes, Cardiac
1
2017
546
0.090
Why?
Area Under Curve
1
2012
332
0.090
Why?
Genetic Predisposition to Disease
2
2017
2399
0.080
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
920
0.080
Why?
Colorado
4
2024
4556
0.080
Why?
Predictive Value of Tests
1
2017
2123
0.080
Why?
Patient Safety
1
2015
356
0.080
Why?
Gastrointestinal Hemorrhage
1
2012
138
0.080
Why?
Anti-Retroviral Agents
1
2013
251
0.080
Why?
Opiate Substitution Treatment
1
2013
189
0.080
Why?
Bayes Theorem
1
2012
421
0.080
Why?
Managed Care Programs
2
2022
140
0.080
Why?
Survival Rate
1
2015
2094
0.080
Why?
Endoscopy, Gastrointestinal
1
2012
237
0.080
Why?
Genome-Wide Association Study
1
2017
1430
0.080
Why?
Pregnancy Outcome
1
2013
504
0.080
Why?
Delivery of Health Care
1
2017
947
0.080
Why?
Multivariate Analysis
1
2012
1547
0.070
Why?
Severity of Illness Index
1
2017
2933
0.070
Why?
Pharmacogenomic Variants
2
2019
35
0.070
Why?
Primary Health Care
1
2019
1737
0.070
Why?
Drug Approval
1
2008
93
0.070
Why?
Emergency Medical Services
1
2015
684
0.070
Why?
Vasodilator Agents
1
2010
330
0.070
Why?
Logistic Models
1
2012
2139
0.060
Why?
Kidney Function Tests
1
2007
156
0.060
Why?
Animals
3
2023
38097
0.060
Why?
Drug-Related Side Effects and Adverse Reactions
1
2008
261
0.060
Why?
Zimbabwe
2
2017
76
0.060
Why?
Drug Therapy, Combination
1
2008
1043
0.060
Why?
Reproducibility of Results
2
2026
3416
0.060
Why?
Models, Biological
1
2012
1764
0.060
Why?
Case-Control Studies
1
2012
3634
0.050
Why?
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
1
2025
39
0.050
Why?
Opioid-Related Disorders
1
2013
605
0.050
Why?
Canada
1
2026
432
0.050
Why?
Psychological Tests
1
2005
130
0.050
Why?
Osteoporosis, Postmenopausal
1
2004
41
0.050
Why?
Potassium Channels
1
2025
148
0.050
Why?
Mandible
1
2004
73
0.050
Why?
Depression
2
2022
1557
0.050
Why?
Cross-Sectional Studies
3
2022
5922
0.050
Why?
Receptors, Adrenergic
1
2023
20
0.050
Why?
Drug Administration Schedule
2
2020
782
0.050
Why?
Cardiovascular Agents
1
2025
166
0.050
Why?
Carcinoembryonic Antigen
1
2002
40
0.040
Why?
Antigens, Differentiation
1
2002
76
0.040
Why?
Child
5
2020
22739
0.040
Why?
Antigens, Bacterial
1
2002
126
0.040
Why?
Electronic Prescribing
1
2021
4
0.040
Why?
Cell Adhesion Molecules
1
2002
181
0.040
Why?
Vitamin K Epoxide Reductases
1
2020
12
0.040
Why?
Health Services Misuse
1
2020
35
0.040
Why?
Antigens, Neoplasm
1
2002
271
0.040
Why?
Insurance Claim Reporting
1
2020
26
0.040
Why?
Antidepressive Agents
1
2022
242
0.040
Why?
Lymphocyte Count
1
2020
165
0.040
Why?
Morbidity
1
2020
322
0.040
Why?
Metoprolol
1
2019
26
0.040
Why?
Membrane Glycoproteins
1
2002
499
0.040
Why?
Antineoplastic Agents
1
2010
2219
0.040
Why?
Grounded Theory
1
2019
44
0.040
Why?
Bias
1
2020
197
0.040
Why?
Aftercare
1
2020
222
0.040
Why?
Antigens, CD
1
2002
558
0.040
Why?
Genomics
1
2024
830
0.030
Why?
Mice, Transgenic
1
2023
2191
0.030
Why?
Coronary Angiography
1
2020
328
0.030
Why?
Amino Acid Sequence
2
2002
2131
0.030
Why?
HIV Infections
1
2013
3195
0.030
Why?
Delivery of Health Care, Integrated
1
2020
303
0.030
Why?
Static Electricity
1
1997
114
0.030
Why?
Molecular Sequence Data
2
2002
2883
0.030
Why?
Exercise Test
1
2020
630
0.030
Why?
Tomography, Emission-Computed, Single-Photon
1
2017
104
0.030
Why?
Inpatients
1
2021
553
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2017
337
0.030
Why?
Socioeconomic Factors
1
2020
1327
0.030
Why?
Frail Elderly
1
2017
136
0.030
Why?
Metabolic Networks and Pathways
1
2017
175
0.030
Why?
Focus Groups
1
2019
572
0.030
Why?
World Health Organization
1
2016
104
0.030
Why?
Puerperal Disorders
1
2016
36
0.030
Why?
Physician-Patient Relations
1
2020
588
0.030
Why?
Neoplasms
1
2010
2913
0.030
Why?
Decision Trees
1
2015
78
0.030
Why?
Drug Combinations
1
2016
396
0.030
Why?
Data Mining
1
2015
113
0.030
Why?
Blood Pressure
1
2020
1782
0.030
Why?
Cell Membrane
1
1997
709
0.020
Why?
Biopsy
1
2017
1082
0.020
Why?
Pediatrics
1
2020
1125
0.020
Why?
Models, Genetic
1
2015
527
0.020
Why?
Liver
1
2020
1899
0.020
Why?
Infant
2
2015
10090
0.020
Why?
Mass Screening
2
2013
1361
0.020
Why?
Anthracyclines
1
2010
49
0.020
Why?
Trastuzumab
1
2010
118
0.020
Why?
Child, Preschool
2
2015
11868
0.020
Why?
Angiotensin Receptor Antagonists
1
2010
115
0.020
Why?
Signal Transduction
1
2023
5223
0.020
Why?
Clinical Trials as Topic
1
2015
1062
0.020
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2010
229
0.020
Why?
Program Evaluation
1
2013
944
0.020
Why?
Apoptosis
1
2017
2443
0.020
Why?
Injections, Intravenous
1
2007
197
0.020
Why?
Natriuretic Peptide, Brain
1
2007
109
0.020
Why?
Ultrasonography
1
2010
788
0.020
Why?
Infusions, Intravenous
1
2007
428
0.020
Why?
Mice
1
2023
18355
0.010
Why?
Creatinine
1
2007
515
0.010
Why?
Hospitals, University
1
2005
176
0.010
Why?
Dentists
1
2004
21
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2010
992
0.010
Why?
Femur Neck
1
2004
62
0.010
Why?
Bone Diseases, Metabolic
1
2004
58
0.010
Why?
Absorptiometry, Photon
1
2004
277
0.010
Why?
Antibodies, Monoclonal
1
2010
1505
0.010
Why?
Nurses
1
2005
171
0.010
Why?
Heparan Sulfate Proteoglycans
1
2002
23
0.010
Why?
Analysis of Variance
1
2004
1300
0.010
Why?
Bone Density
1
2004
487
0.010
Why?
HeLa Cells
1
2002
632
0.010
Why?
Binding Sites
1
2002
1311
0.010
Why?
Clinical Competence
1
2005
1247
0.010
Why?
Physicians
1
2005
956
0.010
Why?
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)